Skip to main content
  • twitter
  • phone
  • email
  • 1-800-4-CANCER
  • Live Help
Hit enter to search or ESC to close
Close Search
Metro Minnesota Community Oncology Research Consortium
  • LOGIN
search
Menu
  • ABOUT
  • TRIALS
  • LOCATIONS
  • FAQ
  • RESOURCES
  • NEWS
  • CONTACT
  • CAREERS
  • LOGIN
  • DONATE
  • search
  • ABOUT
  • TRIALS
  • LOCATIONS
  • FAQ
  • RESOURCES
  • NEWS
  • CONTACT
  • CAREERS
  • DONATE
  • 1-800-4-CANCER
  • Live Help
Tag

AML

Recent Posts

  • MM1OA-S03: A Randomized Phase II Trial of ASTX727 and Venetoclax Compared with ASTX727, Venetoclax, and Enasidenib for Newly Diagnosed Older Adults with IDH2 Mutant Acute Myeloid Leukemia: A myeloMATCH Substudy
  • S2414: A Randomized Phase III Trial Incorporating Pathologic Complete Response in Participants with Early Stage Non-Small Cell Lung Cancer to Optimize Immunotherapy in the Adjuvant Setting (INSIGHT) (NCT06498635)
  • BR.38: Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression in Patients With Metastatic Non-Small-Cell Lung Cancer – A Randomized Phase III Trial (NCT #06686771)
  • S2417CD: A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention Called Current Together After Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance
  • EA5231: A Randomized Phase III Trial of Checkpoint blockade in Lung cancEr patients in the Adjuvant setting based on pathologic Response following neoadjuvant therapy (CLEAR) (NCT06732401)

Recent Comments

No comments to show.

Contact Us

Phone: 952-993-1517 | Fax: 952-993-1550

Email: mmcorc@healthpartners.com

Mailing: 3800 Park Nicollet Blvd., St. Louis Park, MN 55416

Physical: 6465 Wayzata Blvd., Suite 310, St Louis Park, MN 55426

Download the App

Download on the App Store

The Metro-Minnesota Community Oncology Research Consortium (MMCORC) is a nonprofit research program sponsored by the National Cancer Institute (NCI) and participating hospitals and clinics. Local physician have access to the newest advances in cancer research. The MMCORC links community cancer specialists, primary care physicians and other health care professionals to NCI-approved research studies, called clinical trials.

The NCI Community Oncology Research Program (NCORP) brings cancer research studies and results to patients in a variety of community settings across the United States. 7 Research Bases Develop and coordinate clinical trials and cancer care research for 32 Community Sites and 14 Minority/Underserved Community Sites to bring NCI approved trials to patients including 1,000+ locations at diverse, community-based hospitals, private practices and more.

© 2025 Metro Minnesota Community Oncology Research Consortium.

  • twitter
  • phone
  • email